(Q45045266)

8 December 2017

Effects of dosage and CYP2D6-mutated allele on plasma concentration of paroxetine (English)

1 reference

8 December 2017

Kazushi Sawamura

1

1 reference

8 December 2017

Yutaro Suzuki

series ordinal

2

1 reference

8 December 2017

Toshiyuki Someya

series ordinal

3

1 reference

8 December 2017

3 September 2004

1 reference

European Journal of Clinical Pharmacology

8 December 2017

1 reference

8 December 2017

60

1 reference

8 December 2017

8

1 reference

8 December 2017

553-557

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-004-0792-6

8 December 2017

0 references

cites work

Inhibitors of alprazolam metabolism in vitro: effect of serotonin-reuptake-inhibitor antidepressants, ketoconazole and quinidine

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-004-0792-6

Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification

21 January 2018

1 reference

12 December 2020

Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.

1 reference

12 December 2020

Effect of CYP2D6 genotypes on the metabolism of haloperidol in a Japanese psychiatric population.

1 reference

12 December 2020

A review of the metabolism and pharmacokinetics of paroxetine in man.

1 reference

12 December 2020

Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology

1 reference

12 December 2020

Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation.

1 reference

12 December 2020

Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline

1 reference

12 December 2020

Pharmacogenetics of antidepressants: clinical aspects

1 reference

12 December 2020

Relationship of paroxetine disposition to metoprolol metabolic ratio and CYP2D6*10 genotype of Korean subjects

1 reference

12 December 2020

Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis

1 reference

12 December 2020

Plasma concentrations of haloperidol are related to CYP2D6 genotype at low, but not high doses of haloperidol in Korean schizophrenic patients

1 reference

12 December 2020

The relationship between paroxetine and the sparteine oxidation polymorphism

1 reference

12 December 2020

The impact of CYP2C19 and CYP2D6 genotypes on metabolism of amitriptyline in Japanese psychiatric patients

1 reference

12 December 2020

Effects of various factors including the CYP2D6 genotype and coadministration of flunitrazepam on the steady-state plasma concentrations of bromperidol and its reduced metabolite.

1 reference

12 December 2020

Pharmacokinetics of the selective serotonin reuptake inhibitor paroxetine: Nonlinearity and relation to the sparteine oxidation polymorphism

1 reference

12 December 2020

Analysis of the CYP2D6 gene in relation to dextromethorphan O-demethylation capacity in a Japanese population

1 reference

12 December 2020

Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine

1 reference

12 December 2020

10.1007/S00228-004-0792-6

Identifiers

DOI

1 reference

Dimensions Publication ID

8 December 2017

0 references

1 reference